Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease
- 1 August 1979
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 33 (4), 457-477
- https://doi.org/10.1016/0021-9150(79)90038-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Increase of the lipoprotein‐lipase activity in human skeletal muscle during clof ibrate administrationEuropean Journal of Clinical Investigation, 1978
- Comparison of assay methods for selective measurement of plasma lipaseAtherosclerosis, 1977
- Quantitative and qualitative serum lipoprotein analysisAtherosclerosis, 1975
- A Methodological Study of an Intravenous Fat Tolerance Test with IntralipidREmulsionScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.BMJ, 1971
- Serial lipid and lipoprotein responses to the American Heart Association fat-controlled dietAmerican Journal Of Medicine, 1971
- A general method for analysis of covariance structuresBiometrika, 1970
- CONTROLLED TRIAL OF A DIET HIGH IN UNSATURATED FAT FOR PREVENTION OF ATHEROSCLEROTIC COMPLICATIONSThe Lancet, 1968
- The Effect of Nicotinic Acid on the Plasma Free Fatty Acids Demonstration of a Metabolic Type of SympathicolysisActa Medica Scandinavica, 1962
- Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérumClinica Chimica Acta; International Journal of Clinical Chemistry, 1960